360 related articles for article (PubMed ID: 11686231)
1. Helicobacter pylori eradication in functional dyspepsia: new evidence for symptomatic benefit.
Malfertheiner P
Eur J Gastroenterol Hepatol; 2001 Aug; 13 Suppl 2():S9-11. PubMed ID: 11686231
[TBL] [Abstract][Full Text] [Related]
2. Key topics in Helicobacter pylori eradication in the management of the dyspeptic patient: a panel discussion.
Kearney DJ; Mégraud F
Eur J Gastroenterol Hepatol; 2001 Aug; 13 Suppl 2():S17-21. PubMed ID: 11686229
[TBL] [Abstract][Full Text] [Related]
3. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
Veldhuyzen van Zanten S; Fedorak RN; Lambert J; Cohen L; Vanjaka A
Am J Gastroenterol; 2003 Sep; 98(9):1963-9. PubMed ID: 14499772
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
Koskenpato J; Färkkilä M; Sipponen P
Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
Koskenpato J; Farkkilä M; Sipponen P
Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
[TBL] [Abstract][Full Text] [Related]
6. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
7. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Lara LF; Cisneros G; Gurney M; Van Ness M; Jarjoura D; Moauro B; Polen A; Rutecki G; Whittier F
Arch Intern Med; 2003 Sep; 163(17):2079-84. PubMed ID: 14504122
[TBL] [Abstract][Full Text] [Related]
8. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
9. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
Oderda G; Marinello D; Lerro P; Kuvidi M; de'Angelis GL; Ferzetti A; Cucchiara S; Franco MT; Romano C; Strisciuglio P; Pensabene L
Helicobacter; 2004 Aug; 9(4):293-301. PubMed ID: 15270743
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the symptomatology and quality of life in functional dyspepsia before and after Helicobacter pylori eradication treatment].
Ladrón de Guevara L; Peña-Alfaro NG; Padilla L; Lichtinger A; Figueroa S; Shapiro I; Rubinstein M; Di Silvio M
Rev Gastroenterol Mex; 2004; 69(4):203-8. PubMed ID: 15765971
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial.
Ott EA; Mazzoleni LE; Edelweiss MI; Sander GB; Wortmann AC; Theil AL; Somm G; Cartell A; Rivero LF; Uchôa DM; Francesconi CF; Prolla JC
Aliment Pharmacol Ther; 2005 May; 21(10):1231-9. PubMed ID: 15882244
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori eradication lowers esophageal sphincter pressures in functional dyspepsia patients.
Besisik F; Sürücü F; Mungan Z; Dinçer D; Kapran Y; Kaymakoglu S; Cevikbas U
Hepatogastroenterology; 2001; 48(42):1772-5. PubMed ID: 11813622
[TBL] [Abstract][Full Text] [Related]
13. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
[TBL] [Abstract][Full Text] [Related]
14. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
15. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
[TBL] [Abstract][Full Text] [Related]
16. Eradication of Helicobacter pylori infection in the management of patients with dyspepsia and non-ulcer dyspepsia.
Huang JQ; Hunt RH
Yale J Biol Med; 1998; 71(2):125-33. PubMed ID: 10378358
[TBL] [Abstract][Full Text] [Related]
17. Key points from the revised Maastricht Consensus Report: the impact on general practice.
Bazzoli F
Eur J Gastroenterol Hepatol; 2001 Aug; 13 Suppl 2():S3-7. PubMed ID: 11686230
[TBL] [Abstract][Full Text] [Related]
18. Is nonulcer dyspepsia related to Helicobacter pylori infection?
Fennerty MB
Semin Gastrointest Dis; 2001 Jul; 12(3):180-5. PubMed ID: 11478750
[TBL] [Abstract][Full Text] [Related]
19. [Gastritis, dyspepsia and Helicobacter pylori].
de Korwin JD
Rev Prat; 2000 Sep; 50(13):1431-6. PubMed ID: 11019635
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.
Mazzoleni LE; Sander GB; Ott EA; Barros SG; Francesconi CF; Polanczyk CA; Wortmann AC; Theil AL; Fritscher LG; Rivero LF; Cartell A; Edelweiss MI; Uchôa DM; Prolla JC
Dig Dis Sci; 2006 Jan; 51(1):89-98. PubMed ID: 16416218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
